Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01116570
Other study ID # 1001035
Secondary ID 2010-A00288-3120
Status Completed
Phase N/A
First received April 28, 2010
Last updated March 31, 2015
Start date October 2010
Est. completion date January 2015

Study information

Verified date March 2015
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)France: French Data Protection Authority
Study type Interventional

Clinical Trial Summary

It is now accepted that physical activity is not deleterious in myopathies, including muscular dystrophies. In patients suffering from facioscapulohumeral dystrophy (FSHD), aerobic training has been reported to be associated to physiological and functional positive effects without alteration in quality of life. The review papers from Van der Kooi et al. (2005), Cup et al. (2007) and Féasson et al. (2010) suggest that the combination of endurance and strength training is even more relevant. Only a few controlled and randomized studies have been conducted on this topic. The impact of such training programs on the skeletal muscle regenerative capacities has not been yet addressed. Moreover, due to the fact that training programs are mainly performed on short-term supervised periods, there is a lack of knowledge regarding long-term effects, patient's autonomy and whether or not regular exercise practice can be maintained in patient's daily life. Also, only a few experiments have reported an integrative view of the potential benefits of such programs on functional, biological and quality of life.


Description:

Our research project aims at establishing a program of physical training that will fulfill the two following conditions: (i) being compatible with the daily professional, social and family activity of the patients so it can be integrated in their life habits and (ii) being intensive enough to induce functional benefits. This experimental work will be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires. This work will be based on a collaboration between the Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine).

It is accepted that exercise therapy can be recommended for patients with myopathies but long-term training load still has to be determined for each pathology. In the specific context of facioscapulohumeral dystrophy, we aim at associating the scientific evaluation of physical activity benefits and a therapeutic education of patients in order to contribute to recommendations for physicians and physiotherapists. The purpose of this study is to combine an integrated approach with a better understanding of biological process implicated in this physiological treatment strategy.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- facioscapulohumeral dystrophy

- Being capable of supporting an exercise on ergocycle

- Social Security regimen affiliated

- Consent form signed

Exclusion Criteria:

- Severe cardiac or respiratory insufficiency

- Cardiac pacemaker

- Morbid obesity (BMI upper to 35)

- Anti platelet therapy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Physical training
Physical training during 24 weeks
Control
No intervention

Locations

Country Name City State
France CHU de Grenoble Grenoble
France CHU de Saint-Etienne Saint-etienne

Sponsors (3)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Association Française contre les Myopathies (AFM), Paris, Örebro University, Sweden

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary maximal oxygen uptake (VO2max) VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle Week 24 No
Secondary Questionnaire of quality of life "short form 36 health survey questionnaire" SF36 Day 0, Week 6, Week 12, Week 18 and Week 24 No
Secondary Biopsy biopsy of the vastus lateralis muscle Day 0 and Week 24 No
Secondary maximal oxygen uptake (VO2max) VO2max is meseasured directly by respiratory gas analysis during maximal exercise test on ergocycle Week 6, Week 12 and Week 18 No
Secondary Questionnaire of subjective fatigue Fatigue severity scale (FSS) Day 0, Week 6, Week 12, Week 18 and Week 24 No
Secondary nuclear magnetic resonance imaging In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images. Inclusion No
See also
  Status Clinical Trial Phase
Completed NCT01970735 - Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 N/A
Completed NCT02032979 - Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2 N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Completed NCT00004685 - Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy N/A
Recruiting NCT06227182 - Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Completed NCT01689480 - Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program. N/A
Recruiting NCT05747924 - Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) Phase 1/Phase 2
Completed NCT04999735 - Digital Biotyping of FSHD Patients and Controls